Synonyms: | |
Status: | Approved |
Entry Type: | Small molecule |
Molecule Category: | Parent |
UNII: | 94ZLA3W45F |
Parent Compound: | ARGININE |
InChI Key | ODKSFYDXXFIFQN-BYPYZUCNSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C6H14N4O2 |
Molecular Weight | 174.2 |
AlogP | -1.34 |
Hydrogen Bond Acceptor | 3.0 |
Hydrogen Bond Donor | 5.0 |
Number of Rotational Bond | 5.0 |
Polar Surface Area | 125.22 |
Molecular species | ZWITTERION |
Aromatic Rings | 0.0 |
Heavy Atoms | 12.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Protease
Serine protease
Serine protease PA clan
Serine protease S1A subfamily
|
- | - | - | - | 4 | |
Enzyme
|
- | - | 7000-7000 | - | 4 | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC03 and SLC07 families of heteromeric amino acid transporters (HATs)
SLC07 Cationic amino acid transporter/glycoprotein-associated family
|
- | - | - | - | 49-49 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Anemia, Sickle Cell | 3 | D000755 | ClinicalTrials |
Pre-Eclampsia | 3 | D011225 | ClinicalTrials |
Carcinoma, Hepatocellular | 3 | D006528 | ClinicalTrials |
Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
Tuberculosis, Pulmonary | 3 | D014397 | ClinicalTrials |
Hypersensitivity | 3 | D006967 | ClinicalTrials |
Glucose Intolerance | 3 | D018149 | ClinicalTrials |
Severe Acute Respiratory Syndrome | 3 | D045169 | ClinicalTrials |
Small Cell Lung Carcinoma | 2 | D055752 | ClinicalTrials |
MELAS Syndrome | 2 | D017241 | ClinicalTrials |
beta-Thalassemia | 2 | D017086 | ClinicalTrials |
Schizophrenia | 2 | D012559 | ClinicalTrials |
Peripheral Arterial Disease | 2 | D058729 | ClinicalTrials |
Death, Sudden, Cardiac | 2 | D016757 | ClinicalTrials |
Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
Cystic Fibrosis | 2 | D003550 | ClinicalTrials |
Pain | 2 | D010146 | ClinicalTrials |
Asthma | 2 | D001249 | ClinicalTrials |
Galactosemias | 2 | D005693 | ClinicalTrials |
Malaria, Falciparum | 2 | D016778 | ClinicalTrials |
Hepatitis, Alcoholic | 2 | D006519 | ClinicalTrials |
Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
Alzheimer Disease | 2 | D000544 | ClinicalTrials |
Lymphoma | 2 | D008223 | ClinicalTrials |
Dental Caries | 2 | D003731 | ClinicalTrials |
Aortic Aneurysm, Abdominal | 2 | D017544 | ClinicalTrials |
Hernias, Diaphragmatic, Congenital | 2 | D065630 | ClinicalTrials |
Essential Hypertension | 2 | D000075222 | ClinicalTrials |
Sepsis | 2 | D018805 | ClinicalTrials |
Argininosuccinic Aciduria | 2 | D056807 | ClinicalTrials |
Muscular Dystrophy, Duchenne | 1 | D020388 | ClinicalTrials |
Neoplasms | 1 | D009369 | ClinicalTrials |
Liver Cirrhosis | 1 | D008103 | ClinicalTrials |
Diabetes Mellitus, Type 2 | 1 | D003924 | ClinicalTrials |
Glioblastoma | 1 | D005909 | ClinicalTrials |
Hypertension | 1 | D006973 | ClinicalTrials |
Coronary Disease | 1 | D003327 | ClinicalTrials |
Heart Failure | 1 | D006333 | ClinicalTrials |
Kidney Diseases | 0 | D007674 | ClinicalTrials |
Resources | Reference |
---|---|
CAS NUMBER | 74-79-3 |
ChEBI | 16467 |
ChEMBL | CHEMBL1485 |
DrugBank | DB00125 |
DrugCentral | 1549 |
EPA CompTox | DTXSID6041056 |
FDA SRS | 94ZLA3W45F |
Human Metabolome Database | HMDB0000517 |
Guide to Pharmacology | 721 |
KEGG | C00062 |
PharmGKB | PA448478 |
PubChem | 6322 |
SureChEMBL | SCHEMBL1791 |
ZINC | ZINC000001532525 |